In rifampicin-resistant TB, bedaquiline-containing regimens reduced unfavorable status vs. a control regimen at 132 wk.
Saved in:
| Title: | In rifampicin-resistant TB, bedaquiline-containing regimens reduced unfavorable status vs. a control regimen at 132 wk. |
|---|---|
| Authors: | Nachman A; McMaster University, Hamilton, Ontario, Canada (A.N., Z.C.)., Chagla Z; McMaster University, Hamilton, Ontario, Canada (A.N., Z.C.). |
| Corporate Authors: | ACP Journal Club Editorial Team at McMaster University |
| Source: | Annals of internal medicine [Ann Intern Med] 2025 Feb; Vol. 178 (2), pp. JC19. Date of Electronic Publication: 2025 Feb 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1539-3704 (Electronic) Linking ISSN: 00034819 NLM ISO Abbreviation: Ann Intern Med Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1539-3704 |
|---|---|
| DOI: | 10.7326/ANNALS-24-03918-JC |
